Report Says: It is projected that by 2017 this figure will reach USD10.096 billion, exceeding USD10 billion for the first time.
Albany, NY (PRWEB) October 15, 2014
DNA sequencing is the process of reading nucleotide bases in a specific DNA molecule, that is to say determining the arrangement mode of adenine, thymine, cytosine, and guanine. It can be applied in a broad range of fields, including medicine, biology, geology, and agriculture.
View Full Report at http://www.marketresearchreports.biz/analysis/225746
With the advancement of DNA sequencing technology and dramatic decline in sequencing costs, DNA sequencing is increasingly showing its market potential in noninvasive detection, disease diagnosis, and personalized treatment. In 2013, the market size of global DNA sequencing (including equipment and consumables, service and workflow, etc.) approximated USD4.6 billion, up around 26% from the previous year. It is projected that by 2017 this figure will reach USD10.096 billion, exceeding USD10 billion for the first time.
Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/225746
Ever since 1975, DNA sequencing technology has been through four generations, but the fourth-generation technology—Nanopore sequencing is still under development. Due to technologies and costs, the second-generation high-throughput sequencers are the mainstream sequencing platform around the world, with its total number occupying over 95% of next-generation DNA sequencers worldwide.
Explore Other Published Reports By Research in China at http://www.marketresearchreports.biz/publisher/67
The upstream sectors of DNA sequencing industry are extremely robust, with the global market dominated by the second-generation DNA sequencing enterprises including Illumina, Thermo Fisher Scientific (through Life Technologies), Roche and the third-generation sequencing enterprises such as Pacific Biosciences. A review of these giants’ development history shows that mergers and acquisitions are the main driving forces behind the great market power. In February 2014, Roche acquired Life Technologies for USD13.6 billion, making it the industry giant second only to Illumina.
Browse All China Market Research Reports at http://www.marketresearchreports.biz/country/China
In China, the upstream sectors of DNA sequencing industry are virtually monopolized by foreign giants. BGI is the leader in China’s DNA sequencing service, and its second-generation DNA sequencers top the global chart in number. However, two of its sequencers—HiSeq 2000 and Ion Proton were entirely from Illumina and Life Technologies. In March 2013, BGI acquired Complete Genomics, a sign that BGI formally ventured into the upstream sectors of DNA sequencing industry. In June 2014, BGI’s two products—BGISEQ-1000 and BGISEQ-100 became the first second-generation DNA sequencers registered in China.
It is expected, however, that within the next five years the weak position of Chinese enterprises in upstream sectors will remain unchanged except for the epic M&A.
Global And China Stem Cell Industry Report, 2014-2017
View Full Report at http://www.marketresearchreports.biz/analysis/223134
Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatment of cardiovascular diseases, leukemia (a kind of hematological system disease), nervous system diseases, damage or lesion of liver, kidney and other parenchymal organs, etc..
Downlaod Deatail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/223134
Currently, cord blood bank is the fastest-growing and relatively mature market amid stem cell upstream sectors and even the whole industry chain. In 2005, there were 23 cord blood banks worldwide and in 2013 the figure exceeded 480. Global cord blood stem cell (CBSC) storage companies can be roughly divided into two categories: the ones running in a globalized business model, such as Cryo-Cell International and Esperite (formerly known as Cryo-Save Group), and the others giving priority to regional operation e.g. Zhongyuan Union Stem Cell Bioengineering (VCANBIO), Golden Meditech and LifeCell International. However, the companies mainly engaged in cord blood bank business are currently small in scale, only a few with more than 500,000 clients.
Global Bioinformatics Market (By Platforms, Tools And Services And By Applications: Preventive Medicine, Molecular Medicine, Gene Therapy Drug Development And Others) - Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
View Full Report at http://www.marketresearchreports.biz/analysis/225122
Perpetually advancing information technology (IT) and thereby expansion of application area of information technology into biotechnology and life science industry is escalating the growth of the bioinformatics market globally. Bioinformatics is widely used in recording, processing, and converting the data obtained from research and development activities related to life sciences namely, biotechnology, biopharmaceutical, pharmaceutical and agricultural fields; into computerized digital data that can be later used to expedite further research. This report covers the market analysis for various platforms, tools, and services commercially available in bioinformatics technology that helps deliver advanced information technology to ever growing life science fields such as molecular biology, genetics, biotechnology, biopharmaceuticals, and other life sciences.
Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/225122
This research report provides a detailed analysis of the global bioinformatics market and helps in understanding the various driving factors for the growth of the market. The market overview section of bioinformatics market report includes market dynamics and trends, which are further divided into factors such as drivers, restraints, and opportunities that influence the current nature and future status of bioinformatics market globally.
Regenerative Medicine Market (Bone And Joint) (By Technology - Stem Cell Therapy, Biomaterial And Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products And Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
View Full Report With Complete TOC at http://www.marketresearchreports.biz/analysis/138710
U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Moreover, it has included stem cell therapy, tissue engineering and biomaterial under the umbrella of regenerative medicine. Regenerative medicine has wide areas of application such as cardiovascular, neurology, orthopedic and musculoskeletal diseases and disorders. The global market for regenerative medicine bone and joint application is dominated by various bone graft substitute in 2012. However, it is expected that tissue engineering will become a lucrative market in future. Factors such as growing geriatric population, favorable government support and increasing bone and joint reconstructive surgeries accentuate growth of the global regenerative medicine bone and joint application market.
Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/138710
This research report explains various advancements occurring in this market and analyzes the global regenerative medicine (bone and joint) market by technology and application. The regenerative medicine bone and joint application market by technology is further segmented into stem cell therapy, biomaterials and tissue engineering. Likewise, on basis of application the global regenerative medicine (bone and joint) market is segmented as bone graft substitutes, osteoarticular diseases, allogenic bones, autogenic bone and others.
Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Browse Blog at http://businessmonitorinternational.wordpress.com/